Global Varicella Attenuated Live Vaccine Sales Market Report 2023

SKU ID : QYR-22289675 | Publishing Date : 02-Jan-2023 | No. of pages : 117

Request a free Sample

Detailed TOC of Global Varicella Attenuated Live Vaccine Sales Market Report 2023

1 Varicella Attenuated Live Vaccine Market Overview
    1.1 Varicella Attenuated Live Vaccine Product Scope
    1.2 Varicella Attenuated Live Vaccine Segment by Type
        1.2.1 Global Varicella Attenuated Live Vaccine Sales by Type (2018 & 2022 & 2029)
        1.2.2 Monovalent Vaccine
        1.2.3 Combination Vaccine
    1.3 Varicella Attenuated Live Vaccine Segment by Application
        1.3.1 Global Varicella Attenuated Live Vaccine Sales Comparison by Application (2018 & 2022 & 2029)
        1.3.2 Kids Injection
        1.3.3 Adults Injection
    1.4 Varicella Attenuated Live Vaccine Market Estimates and Forecasts (2018-2029)
        1.4.1 Global Varicella Attenuated Live Vaccine Market Size in Value Growth Rate (2018-2029)
        1.4.2 Global Varicella Attenuated Live Vaccine Market Size in Volume Growth Rate (2018-2029)
        1.4.3 Global Varicella Attenuated Live Vaccine Price Trends (2018-2029)
2 Varicella Attenuated Live Vaccine Estimates and Forecasts by Region
    2.1 Global Varicella Attenuated Live Vaccine Market Size by Region: 2018 VS 2022 VS 2029
    2.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario by Region (2018-2023)
        2.2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2018-2023)
        2.2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2018-2023)
    2.3 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Region (2024-2029)
        2.3.1 Global Varicella Attenuated Live Vaccine Sales Estimates and Forecasts by Region (2024-2029)
        2.3.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2024-2029)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 United States Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
        2.4.2 Europe Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
        2.4.3 China Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
        2.4.4 Japan Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
        2.4.5 Southeast Asia Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
        2.4.6 India Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029)
3 Global Varicella Attenuated Live Vaccine Competition Landscape by Players
    3.1 Global Top Varicella Attenuated Live Vaccine Players by Sales (2018-2023)
    3.2 Global Top Varicella Attenuated Live Vaccine Players by Revenue (2018-2023)
    3.3 Global Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Attenuated Live Vaccine as of 2022)
    3.4 Global Varicella Attenuated Live Vaccine Average Price by Company (2018-2023)
    3.5 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Varicella Attenuated Live Vaccine Market Size by Type
    4.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Type (2018-2023)
        4.1.1 Global Varicella Attenuated Live Vaccine Sales by Type (2018-2023)
        4.1.2 Global Varicella Attenuated Live Vaccine Revenue by Type (2018-2023)
        4.1.3 Global Varicella Attenuated Live Vaccine Price by Type (2018-2023)
    4.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Type (2024-2029)
        4.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2024-2029)
        4.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Type (2024-2029)
        4.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Type (2024-2029)
5 Global Varicella Attenuated Live Vaccine Market Size by Application
    5.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Application (2018-2023)
        5.1.1 Global Varicella Attenuated Live Vaccine Sales by Application (2018-2023)
        5.1.2 Global Varicella Attenuated Live Vaccine Revenue by Application (2018-2023)
        5.1.3 Global Varicella Attenuated Live Vaccine Price by Application (2018-2023)
    5.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Application (2024-2029)
        5.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Application (2024-2029)
        5.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Application (2024-2029)
        5.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Application (2024-2029)
6 United States Varicella Attenuated Live Vaccine Market Facts & Figures
    6.1 United States Varicella Attenuated Live Vaccine Sales by Company
        6.1.1 United States Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        6.1.2 United States Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    6.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type
        6.2.1 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        6.2.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    6.3 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application
        6.3.1 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        6.3.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
7 Europe Varicella Attenuated Live Vaccine Market Facts & Figures
    7.1 Europe Varicella Attenuated Live Vaccine Sales by Company
        7.1.1 Europe Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        7.1.2 Europe Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    7.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type
        7.2.1 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        7.2.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    7.3 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application
        7.3.1 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        7.3.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
8 China Varicella Attenuated Live Vaccine Market Facts & Figures
    8.1 China Varicella Attenuated Live Vaccine Sales by Company
        8.1.1 China Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        8.1.2 China Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    8.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Type
        8.2.1 China Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        8.2.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    8.3 China Varicella Attenuated Live Vaccine Sales Breakdown by Application
        8.3.1 China Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        8.3.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
9 Japan Varicella Attenuated Live Vaccine Market Facts & Figures
    9.1 Japan Varicella Attenuated Live Vaccine Sales by Company
        9.1.1 Japan Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        9.1.2 Japan Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    9.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type
        9.2.1 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        9.2.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    9.3 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application
        9.3.1 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        9.3.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
10 Southeast Asia Varicella Attenuated Live Vaccine Market Facts & Figures
    10.1 Southeast Asia Varicella Attenuated Live Vaccine Sales by Company
        10.1.1 Southeast Asia Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        10.1.2 Southeast Asia Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    10.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type
        10.2.1 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        10.2.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    10.3 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application
        10.3.1 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        10.3.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
11 India Varicella Attenuated Live Vaccine Market Facts & Figures
    11.1 India Varicella Attenuated Live Vaccine Sales by Company
        11.1.1 India Varicella Attenuated Live Vaccine Sales by Company (2018-2023)
        11.1.2 India Varicella Attenuated Live Vaccine Revenue by Company (2018-2023)
    11.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Type
        11.2.1 India Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023)
        11.2.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029)
    11.3 India Varicella Attenuated Live Vaccine Sales Breakdown by Application
        11.3.1 India Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023)
        11.3.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Varicella Attenuated Live Vaccine Business
    12.1 Merck
        12.1.1 Merck Corporation Information
        12.1.2 Merck Business Overview
        12.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.1.4 Merck Varicella Attenuated Live Vaccine Products Offered
        12.1.5 Merck Recent Development
    12.2 BCHT
        12.2.1 BCHT Corporation Information
        12.2.2 BCHT Business Overview
        12.2.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.2.4 BCHT Varicella Attenuated Live Vaccine Products Offered
        12.2.5 BCHT Recent Development
    12.3 Shanghai Institute
        12.3.1 Shanghai Institute Corporation Information
        12.3.2 Shanghai Institute Business Overview
        12.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.3.4 Shanghai Institute Varicella Attenuated Live Vaccine Products Offered
        12.3.5 Shanghai Institute Recent Development
    12.4 GSK
        12.4.1 GSK Corporation Information
        12.4.2 GSK Business Overview
        12.4.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.4.4 GSK Varicella Attenuated Live Vaccine Products Offered
        12.4.5 GSK Recent Development
    12.5 Keygen
        12.5.1 Keygen Corporation Information
        12.5.2 Keygen Business Overview
        12.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.5.4 Keygen Varicella Attenuated Live Vaccine Products Offered
        12.5.5 Keygen Recent Development
    12.6 Green Cross
        12.6.1 Green Cross Corporation Information
        12.6.2 Green Cross Business Overview
        12.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.6.4 Green Cross Varicella Attenuated Live Vaccine Products Offered
        12.6.5 Green Cross Recent Development
    12.7 Biken
        12.7.1 Biken Corporation Information
        12.7.2 Biken Business Overview
        12.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.7.4 Biken Varicella Attenuated Live Vaccine Products Offered
        12.7.5 Biken Recent Development
    12.8 Shanghai Rongsheng Biotech
        12.8.1 Shanghai Rongsheng Biotech Corporation Information
        12.8.2 Shanghai Rongsheng Biotech Business Overview
        12.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.8.4 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Products Offered
        12.8.5 Shanghai Rongsheng Biotech Recent Development
    12.9 Changchun Changsheng Life Sciences Limited
        12.9.1 Changchun Changsheng Life Sciences Limited Corporation Information
        12.9.2 Changchun Changsheng Life Sciences Limited Business Overview
        12.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
        12.9.4 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Products Offered
        12.9.5 Changchun Changsheng Life Sciences Limited Recent Development
13 Varicella Attenuated Live Vaccine Manufacturing Cost Analysis
    13.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
    13.4 Varicella Attenuated Live Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Varicella Attenuated Live Vaccine Distributors List
    14.3 Varicella Attenuated Live Vaccine Customers
15 Market Dynamics
    15.1 Varicella Attenuated Live Vaccine Industry Trends
    15.2 Varicella Attenuated Live Vaccine Market Drivers
    15.3 Varicella Attenuated Live Vaccine Market Challenges
    15.4 Varicella Attenuated Live Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer

List of Figures, Tables and Charts Available in Global Varicella Attenuated Live Vaccine Sales Market Report 2023

List of Tables
    Table 1. Global Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
    Table 2. Global Varicella Attenuated Live Vaccine Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
    Table 3. Global Varicella Attenuated Live Vaccine Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
    Table 4. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Region (2018-2023)
    Table 5. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2018-2023)
    Table 6. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Region (2018-2023))
    Table 7. Global Varicella Attenuated Live Vaccine Revenue Share by Region (2018-2023)
    Table 8. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Region (2024-2029)
    Table 9. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2024-2029)
    Table 10. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Forecast by Region (2024-2029)
    Table 11. Global Varicella Attenuated Live Vaccine Revenue Share Forecast by Region (2024-2029)
    Table 12. Global Varicella Attenuated Live Vaccine Sales by Company (K Doses) & (2018-2023)
    Table 13. Global Varicella Attenuated Live Vaccine Sales Share by Company (2018-2023)
    Table 14. Global Varicella Attenuated Live Vaccine Revenue by Company (US$ Million) & (2018-2023)
    Table 15. Global Varicella Attenuated Live Vaccine Revenue Share by Company (2018-2023)
    Table 16. Global Varicella Attenuated Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Attenuated Live Vaccine as of 2022)
    Table 17. Global Market Varicella Attenuated Live Vaccine Average Price by Company (USD/Dose) & (2018-2023)
    Table 18. Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites and Area Served
    Table 19. Manufacturers Varicella Attenuated Live Vaccine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 22. Global Varicella Attenuated Live Vaccine Sales Share by Type (2018-2023)
    Table 23. Global Varicella Attenuated Live Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 24. Global Varicella Attenuated Live Vaccine Price by Type (2018-2023) & (USD/Dose)
    Table 25. Global Varicella Attenuated Live Vaccine Sales by Type (2024-2029)
    Table 26. Global Varicella Attenuated Live Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 27. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2024-2029)
    Table 28. Global Varicella Attenuated Live Vaccine Price by Type (2024-2029) & (USD/Dose)
    Table 29. Global Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 30. Global Varicella Attenuated Live Vaccine Sales Share by Application (2018-2023)
    Table 31. Global Varicella Attenuated Live Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 32. Global Varicella Attenuated Live Vaccine Price by Application (2018-2023) & (USD/Dose)
    Table 33. Global Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 34. Global Varicella Attenuated Live Vaccine Sales Share by Application (2024-2029)
    Table 35. Global Varicella Attenuated Live Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2024-2029)
    Table 37. Global Varicella Attenuated Live Vaccine Price by Application (2024-2029) & (USD/Dose)
    Table 38. United States Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 39. United States Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 40. United States Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 41. United States Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 42. United States Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 43. United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 44. United States Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 45. United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 46. United States Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 47. United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 48. United States Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 49. United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 50. Europe Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 51. Europe Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 52. Europe Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 53. Europe Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 54. Europe Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 55. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 56. Europe Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 57. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 58. Europe Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 59. Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 60. Europe Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 61. Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 62. China Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 63. China Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 64. China Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 65. China Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 66. China Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 67. China Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 68. China Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 69. China Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 70. China Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 71. China Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 72. China Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 73. China Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 74. Japan Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 75. Japan Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 76. Japan Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 77. Japan Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 78. Japan Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 79. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 80. Japan Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 81. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 82. Japan Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 83. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 84. Japan Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 85. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 86. Southeast Asia Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 87. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 88. Southeast Asia Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 89. Southeast Asia Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 90. Southeast Asia Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 91. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 92. Southeast Asia Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 93. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 94. Southeast Asia Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 95. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 96. Southeast Asia Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 97. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 98. India Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 99. India Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
    Table 100. India Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 101. India Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
    Table 102. India Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 103. India Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
    Table 104. India Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 105. India Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029)
    Table 106. India Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 107. India Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
    Table 108. India Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 109. India Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029)
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Business Overview
    Table 112. Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 113. Merck Varicella Attenuated Live Vaccine Product
    Table 114. Merck Recent Development
    Table 115. BCHT Corporation Information
    Table 116. BCHT Description and Business Overview
    Table 117. BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 118. BCHT Varicella Attenuated Live Vaccine Product
    Table 119. BCHT Recent Development
    Table 120. Shanghai Institute Corporation Information
    Table 121. Shanghai Institute Description and Business Overview
    Table 122. Shanghai Institute Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 123. Shanghai Institute Varicella Attenuated Live Vaccine Product
    Table 124. Shanghai Institute Recent Development
    Table 125. GSK Corporation Information
    Table 126. GSK Description and Business Overview
    Table 127. GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 128. GSK Varicella Attenuated Live Vaccine Product
    Table 129. GSK Recent Development
    Table 130. Keygen Corporation Information
    Table 131. Keygen Description and Business Overview
    Table 132. Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 133. Keygen Varicella Attenuated Live Vaccine Product
    Table 134. Keygen Recent Development
    Table 135. Green Cross Corporation Information
    Table 136. Green Cross Description and Business Overview
    Table 137. Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 138. Green Cross Varicella Attenuated Live Vaccine Product
    Table 139. Green Cross Recent Development
    Table 140. Biken Corporation Information
    Table 141. Biken Description and Business Overview
    Table 142. Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 143. Biken Varicella Attenuated Live Vaccine Product
    Table 144. Biken Recent Development
    Table 145. Shanghai Rongsheng Biotech Corporation Information
    Table 146. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 147. Shanghai Rongsheng Biotech Description and Business Overview
    Table 148. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product
    Table 149. Shanghai Rongsheng Biotech Recent Development
    Table 150. Changchun Changsheng Life Sciences Limited Corporation Information
    Table 151. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 152. Changchun Changsheng Life Sciences Limited Description and Business Overview
    Table 153. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product
    Table 154. Changchun Changsheng Life Sciences Limited Recent Development
    Table 155. Production Base and Market Concentration Rate of Raw Material
    Table 156. Key Suppliers of Raw Materials
    Table 157. Varicella Attenuated Live Vaccine Distributors List
    Table 158. Varicella Attenuated Live Vaccine Customers List
    Table 159. Varicella Attenuated Live Vaccine Market Trends
    Table 160. Varicella Attenuated Live Vaccine Market Drivers
    Table 161. Varicella Attenuated Live Vaccine Market Challenges
    Table 162. Varicella Attenuated Live Vaccine Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Varicella Attenuated Live Vaccine Product Picture
    Figure 2. Global Varicella Attenuated Live Vaccine Sales (US$ Million) by Type (2018 & 2022 & 2029)
    Figure 3. Global Varicella Attenuated Live Vaccine Sales Market Share by Type in 2022 & 2029
    Figure 4. Monovalent Vaccine Product Picture
    Figure 5. Combination Vaccine Product Picture
    Figure 6. Global Varicella Attenuated Live Vaccine Sales (US$ Million) by Application (2018 & 2022 & 2029)
    Figure 7. Global Varicella Attenuated Live Vaccine Sales Market Share by Application in 2022 & 2029
    Figure 8. Kids Injection Examples
    Figure 9. Adults Injection Examples
    Figure 10. Global Varicella Attenuated Live Vaccine Sales, (US$ Million), 2018 VS 2022 VS 2029
    Figure 11. Global Varicella Attenuated Live Vaccine Sales Growth Rate (2018-2029) & (US$ Million)
    Figure 12. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2018-2029)
    Figure 13. Global Varicella Attenuated Live Vaccine Price Trends Growth Rate (2018-2029) & (USD/Dose)
    Figure 14. Global Market Varicella Attenuated Live Vaccine Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
    Figure 15. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region: 2018 VS 2022
    Figure 16. United States Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 17. United States Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2018-2029)
    Figure 18. Europe Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 19. Europe Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029)
    Figure 20. China Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 21. China Varicella Attenuated Live Vaccine Sales (US$ Million) and Growth Rate (2018-2029)
    Figure 22. Japan Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 23. Japan Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029)
    Figure 24. Southeast Asia Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 25. Southeast Asia Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029)
    Figure 26. India Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 27. India Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029)
    Figure 28. Global 5 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue in Varicella Attenuated Live Vaccine: 2018 & 2022
    Figure 29. Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2018-2023)
    Figure 31. Global Varicella Attenuated Live Vaccine Sales Share by Type (2024-2029)
    Figure 32. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2024-2029)
    Figure 33. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2018-2023)
    Figure 34. Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Application in 2018 & 2022
    Figure 35. Global Varicella Attenuated Live Vaccine Sales Share by Application (2024-2029)
    Figure 36. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2024-2029)
    Figure 37. Key Raw Materials Price Trend
    Figure 38. Manufacturing Cost Structure of Varicella Attenuated Live Vaccine
    Figure 39. Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
    Figure 40. Varicella Attenuated Live Vaccine Industrial Chain Analysis
    Figure 41. Channels of Distribution
    Figure 42. Distributors Profiles
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed